Development of CAR T cells designed to improve antitumor efficacy and safety.
about
T Cell Receptor Profiling in Type 1 Diabetes.Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes.Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.Cell and Gene Therapy for HIV Cure.Methods and practices to diversify cell-based products.Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimens.'Atypical' CAR T cells: NKG2D and Erb-B as examples of natural receptor/ligands to target recalcitrant solid tumors.Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice.Cationic polymers for non-viral gene delivery to human T cells.Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies.Versatile CAR T-cells for cancer immunotherapy.
P2860
Q42374922-D3D54DE7-DEA1-4EB8-98CA-BBE5B7B16543Q46453590-474CD334-93B1-4C2B-A34B-11A22F04C074Q46900302-D931DDF0-AA80-4CF3-8465-7628551B78E4Q47236016-32867DFB-337D-40F7-A9F6-84DB697F0CFCQ47246973-7A4F6349-3063-47AF-A4ED-D1C7B53CBF6EQ47629566-A165E3D1-C00D-4EE4-B8CE-124091CAF8D1Q47849932-F7D2E84A-68B2-4862-909A-EBFAAD45C5D0Q48507616-CB56FED1-80DC-45EC-A593-BCAD8C3B3D25Q54259697-1BAB844A-F0A6-4A51-BA45-132B4FBD9A22Q55216327-68520EF4-9184-469D-A1F3-37F49E6B2E0AQ55347731-E1A3DC32-D7A0-4DE5-A451-D41F4E96074A
P2860
Development of CAR T cells designed to improve antitumor efficacy and safety.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Development of CAR T cells designed to improve antitumor efficacy and safety.
@en
Development of CAR T cells designed to improve antitumor efficacy and safety.
@nl
type
label
Development of CAR T cells designed to improve antitumor efficacy and safety.
@en
Development of CAR T cells designed to improve antitumor efficacy and safety.
@nl
prefLabel
Development of CAR T cells designed to improve antitumor efficacy and safety.
@en
Development of CAR T cells designed to improve antitumor efficacy and safety.
@nl
P2860
P1476
Development of CAR T cells designed to improve antitumor efficacy and safety.
@en
P2093
Janneke E Jaspers
Renier J Brentjens
P2860
P356
10.1016/J.PHARMTHERA.2017.03.012
P577
2017-03-22T00:00:00Z